Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging

Journal of the Neurological Sciences

Volumn 361, Issue , 2016, Pages 87-91

  Wieler, Marguerite ^a   Gee, Myrlene ^a   Camicioli, Richard ^a   Martin, W R Wayne ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Freezing; Gait; Iron; Midbrain; MRI; Parkinson's disease

Indexed keywords

AMANTADINE; IRON; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE;

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; FEMALE; FOLLOW UP; FREEZING OF GAIT; GAIT DISORDER; HUMAN; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS COMPACTA; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING; GAIT; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SUBSTANTIA NIGRA;

AGED; FEMALE; GAIT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84958981472     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.12.008     Document Type: Article

References (31)

1. M.A. Hely, J.G. Morris, R. Traficante, W.G. Reid, D.J. O'Sullivan, and P.M. Williamson The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years J. Neurol. Neurosurg. Psychiatry 67 3 Sep 1999 300 307
2. R.E. Burke, and K. O'Malley Axon degeneration in Parkinson's disease Exp. Neurol. 246 Aug 2013 72 83
3. S. Greffard, M. Verny, A.M. Bonnet, J.Y. Beinis, C. Gallinari, S. Meaume, and et al. Motor score of the Unified Parkinson disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra Arch. Neurol. 63 4 Apr 2006 584 588
4. C.S. Lee, M. Schulzer, E.K. Mak, B.J. Snow, J.K. Tsui, S. Calne, and et al. Clinical observations on the rate of progression of idiopathic parkinsonism Brain 117 Pt 3 Jun 1994 501 507
5. M. Wieler, M. Gee, and W.R. Martin Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R∗/MRI Parkinsonism Relat. Disord. 29 Nov 2014
6. N. Giladi, D. McMahon, S. Przedborski, E. Flaster, S. Guillory, V. Kostic, and et al. Motor blocks in Parkinson's disease Neurology 42 2 Feb 1992 333 339
7. W.R. Martin, M. Wieler, and M. Gee Midbrain iron content in early Parkinson disease: a potential biomarker of disease status Neurology 70 16 Pt 2 Apr 15 2008 1411 1417
8. W.R. Martin, M. Wieler, A.J. Stoessl, and M. Schulzer Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease Ann. Neurol. 63 3 Mar 2008 388 394
9. W.R. Martin, M. Wieler, M. Gee, and R. Camicioli Temporal lobe changes in early, untreated Parkinson's disease Mov. Disord. 24 13 Oct 15 2009 1949 1954
10. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J. Neurol. Neurosurg. Psychiatry 55 3 Mar 1992 181 184
11. S. Fahn, R.L. Elton, and UPDRS Development Committee Unified Parkinson's Disease Rating Scale S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein, Recent Developments in Parkinson's Disease 1987 Macmillan Florham Park, NJ 153 163
12. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". a practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 3 Nov 1975 189 198
13. D. Podsiadlo, and S. Richardson The timed "up & go": a test of basic functional mobility for frail elderly persons J. Am. Geriatr. Soc. 39 2 Feb 1991 142 148
14. K.O. Berg, S.L. Wood-Dauphinee, J.I. Williams, and B. Maki Measuring balance in the elderly: validation of an instrument Can. J. Public Health 83 Suppl. 2 Jul-Aug 1992 S7 11
15. V. Peto, C. Jenkinson, and R. Fitzpatrick PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures J. Neurol. 245 Suppl. 1 May 1998 S10 S14
16. J.M. Wild, W.R. Martin, and P.S. Allen Multiple gradient echo sequence optimized for rapid, single-scan mapping of R(2)(∗) at high B0 Magn. Reson. Med. 48 5 Nov 2002 867 876
17. C.L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C.E. Clarke Systematic review of levodopa dose equivalency reporting in Parkinson's disease Mov. Disord. 25 15 Nov 15 2010 2649 2653
18. R.A. Hauser, and N.H. Holford Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease Mov. Disord. 17 5 Sep 2002 961 968
19. F.Q. Ye, W.R. Martin, and P.S. Allen Estimation of brain iron in vivo by means of the interecho time dependence of image contrast Magn. Reson. Med. 36 1 Jul 1996 153 158
20. D. Berg, C. Siefker, and G. Becker Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings J. Neurol. 248 8 Aug 2001 684 689
21. D. Berg, G. Becker, B. Zeiler, O. Tucha, E. Hofmann, M. Preier, and et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound Neurology 53 5 Sep 22 1999 1026 1031
22. D. Berg, B. Merz, K. Reiners, M. Naumann, and G. Becker Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease Mov. Disord. 20 3 Mar 2005 383 385
23. E.S. Manova, C.A. Habib, A.S. Boikov, M. Ayaz, A. Khan, W.M. Kirsch, and et al. Characterizing the mesencephalon using susceptibility-weighted imaging AJNR Am. J. Neuroradiol. 30 3 Mar 2009 569 574
24. A.K. Lotfipour, S. Wharton, S.T. Schwarz, V. Gontu, A. Schafer, A.M. Peters, and et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease J. Magn. Reson. Imaging 35 1 Jan 2012 48 55
25. A. Nieuwboer, L. Rochester, T. Herman, W. Vandenberghe, G.E. Emil, T. Thomaes, and et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers Gait Posture 30 4 Nov 2009 459 463
26. N. Giladi, H. Shabtaia, E.S. Simona, S. Biranb, J. Talc, and A.D. Korczyna Construction of freezing of gait questionnaire for patients with parkinsonism Parkinsonism Relat. Disord. 6 2000 165-165
27. N. Giladi, M.P. McDermott, S. Fahn, S. Przedborski, J. Jankovic, M. Stern, and et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort Neurology 56 12 Jun 26 2001 1712 1721
28. D.M. Tan, J.L. McGinley, M.E. Danoudis, R. Iansek, and M.E. Morris Freezing of gait and activity limitations in people with Parkinson's disease Arch. Phys. Med. Rehabil. 92 7 Jul 2011 1159 1165
29. N. Giladi, R. Kao, and S. Fahn Freezing phenomenon in patients with parkinsonian syndromes Mov. Disord. 12 3 May 1997 302 305
30. O. Moore, C. Peretz, and N. Giladi Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait Mov. Disord. 22 15 Nov 15 2007 2192 2195
31. I. Lim, E. van Wegen, D. Jones, L. Rochester, A. Nieuwboer, A.M. Willems, and et al. Identifying fallers with Parkinson's disease using home-based tests: who is at risk? Mov. Disord. 23 16 Dec 15 2008 2411 2415